Sol-Gel Technologies (SLGL) Revenue (QoQ) (2018 - 2026)
Sol-Gel Technologies (SLGL) Revenue (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.48% |
| Dec 31, 2025 | 74.00% |
| Sep 30, 2025 | -97.68% |
| Jun 30, 2025 | 1,574.20% |
| Mar 31, 2025 | 270.86% |
| Dec 31, 2024 | -94.81% |
| Sep 30, 2024 | -1.33% |
| Dec 31, 2023 | 109.86% |
| Sep 30, 2023 | -64.14% |
| Dec 31, 2022 | -61.69% |
| Sep 30, 2022 | -92.58% |
| Jun 30, 2022 | -99.88% |
| Mar 31, 2022 | 14,318.22% |
| Dec 31, 2021 | 1,457.41% |
| Sep 30, 2021 | 43.97% |
| Jun 30, 2021 | 32.38% |
| Mar 31, 2021 | -65.92% |
| Dec 31, 2020 | -2.79% |
| Sep 30, 2020 | 86.76% |
| Jun 30, 2020 | -67.30% |